THIAZOLIDINEDIONE DERIVATIVES IN TREATMENT OF DIABETES MELLITUS OF TYPE 2

摘要

A method for the treatment of diabetes mellitus, especially Type 2 diabetes in a mammal, such as a human, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser, such as Compound (I) to a mammal in need thereof, wherein the mammal is not suffering from heart failure (or reduced cardiac reserve).